{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:04:35Z","timestamp":1775012675636,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T00:00:00Z","timestamp":1595116800000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RI 2905\/3-1"],"award-info":[{"award-number":["RI 2905\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Objective of the \u2018German hyperthermic intrathoracic chemotherapy (HITOC) study\u2019 is to evaluate the HITOC as additional treatment after surgical cytoreduction for malignant pleural tumours. Even though HITOC is applied with increasing frequency, there is no standardised therapy protocol concerning the technique of HITOC, the selection as well as dosage of chemotherapeutic agents and perioperative management in order to provide a safe and comparable, standardised treatment regime.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This trial is a retrospective, multicentre observational study, which is funded by the German Research Foundation. Approximately 300 patients will be included. Four departments of thoracic surgery, which are performing the most HITOC procedures in Germany, are contributing to this study: Center for Thoracic Surgery at the University Hospital Regensburg, Thoracic Clinic Heidelberg of the University of Heidelberg, Center for Thoracic Surgery of the Hospital University of Munich and the Department of Thoracic Surgery at the University Hospital Freiburg. All patients who underwent surgical cytoreduction and subsequent HITOC at one of the four centres between starting the HITOC programme in 2008 and December 2019 will be included. Information on the performed HITOC will be obtained, focusing on the technique as well as the applied perfusion solution including the chemotherapeutic agent. Furthermore, parameters of the patient\u2019s postoperative recovery will be analysed to determine 30-day morbidity and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The approvals by the local ethics committee of the respective clinic and the three participating clinics have been obtained. The results will be presented in conferences and published in a peer-reviewed journal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>German Clinical Trials Registry (DRKS00015012; Pre-results).<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041511","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T06:03:04Z","timestamp":1595311384000},"page":"e041511","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-6206","authenticated-orcid":false,"given":"Till","family":"Markowiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Huppertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Stefan","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"2020072023031198000_10.7.e041511.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.12.037"},{"key":"2020072023031198000_10.7.e041511.2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs418"},{"key":"2020072023031198000_10.7.e041511.3","article-title":"Surgical cytoreduction and HITOC for thymic malignancies with pleural dissemination","author":"Markowiak","year":"2019","journal-title":"Thorac Cardiovasc Surg"},{"key":"2020072023031198000_10.7.e041511.4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/fon.14.256","article-title":"Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience","volume":"11","author":"Migliore","year":"2015","journal-title":"Future Oncol"},{"key":"2020072023031198000_10.7.e041511.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.2.480"},{"key":"2020072023031198000_10.7.e041511.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6813"},{"key":"2020072023031198000_10.7.e041511.7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jtho.2018.04.032","article-title":"A phase I trial of surgical resection and intraoperative hyperthermic cisplatin and gemcitabine for pleural mesothelioma","volume":"13","author":"Burt","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2020072023031198000_10.7.e041511.8","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jtcvs.2017.10.070","article-title":"Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: a 10-year experience","volume":"155","author":"Ambrogi","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2020072023031198000_10.7.e041511.9","article-title":"Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: a systematic review and meta-analysis","volume":"96","author":"Zhou","year":"2017","journal-title":"Medicine"},{"key":"2020072023031198000_10.7.e041511.10","unstructured":"Ried M , Hofmann HS , Dienemann H , et al . Implementation of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Germany]. Zentralbl Chir 2018."},{"key":"2020072023031198000_10.7.e041511.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.07.055"},{"key":"2020072023031198000_10.7.e041511.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.02.046"},{"key":"2020072023031198000_10.7.e041511.13","first-page":"89","article-title":"[Expert Recommendation for the Implementation of Hyperthermic Intrathoracic Chemotherapy (HITOC) in Germany]","volume":"145","author":"Ried","year":"2020","journal-title":"Zentralbl Chir"},{"key":"2020072023031198000_10.7.e041511.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.01.039"},{"key":"2020072023031198000_10.7.e041511.15","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu217"},{"key":"2020072023031198000_10.7.e041511.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"2020072023031198000_10.7.e041511.17","doi-asserted-by":"crossref","DOI":"10.1186\/1749-8090-9-125","article-title":"Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion","volume":"9","author":"Kerscher","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"2020072023031198000_10.7.e041511.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(01)02786-2"},{"key":"2020072023031198000_10.7.e041511.19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/OTT.S41347","article-title":"Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination","volume":"6","author":"Yu","year":"2013","journal-title":"Onco Targets Ther"},{"key":"2020072023031198000_10.7.e041511.20","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezv039"},{"key":"2020072023031198000_10.7.e041511.21","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23321"},{"key":"2020072023031198000_10.7.e041511.22","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jso.25726","article-title":"Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy","volume":"120","author":"Markowiak","year":"2019","journal-title":"J Surg Oncol"},{"key":"2020072023031198000_10.7.e041511.23","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910615)67:12<2984::AID-CNCR2820671208>3.0.CO;2-Q"},{"key":"2020072023031198000_10.7.e041511.24","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f21129"},{"key":"2020072023031198000_10.7.e041511.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.02.014","article-title":"Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymoma","volume":"108","author":"Maury","year":"2017","journal-title":"Lung Cancer"},{"key":"2020072023031198000_10.7.e041511.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.10.013"},{"key":"2020072023031198000_10.7.e041511.27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11748-015-0535-x","article-title":"Interim results of pleurectomy\/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy","volume":"63","author":"Ishibashi","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2020072023031198000_10.7.e041511.28","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9508-3"},{"key":"2020072023031198000_10.7.e041511.29","doi-asserted-by":"publisher","DOI":"10.1063\/1.337199"},{"key":"2020072023031198000_10.7.e041511.30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ejso.2017.02.010","article-title":"Is less also better? A single-institution experience on treatment of early stage malignant pleural mesothelioma","volume":"43","author":"Bertoglio","year":"2017","journal-title":"Eur J Surg Oncol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:24:39Z","timestamp":1601051079000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,20]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjopen-2020-041511"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041511","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}